Call Options Transactions Made in Q4 2023 in Rocket Pharmaceuticals, Inc. (RCKT)
This table provides information about the institutional ownership of Rocket Pharmaceuticals, Inc. (RCKT) during Q4 2023. The information is specifically focused on institutions that hold call options of ROCKET PHARMACEUTICALS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2024
Q4 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
CALL |
149K+ 9900.0% |
$2.49M - $4.74M
|
150K
$1.76M
|
|
Feb 14, 2024
Q4 2023
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
53.2K+ 211.11% |
$893K - $1.7M
|
78.4K
$922K
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
CALL |
47.4KNew |
$795K - $1.51M
|
47.4K
$557K
|
|
Feb 14, 2024
Q4 2023
|
Caption Management, LLC
Oklahoma City, OK |
BUY
|
CALL |
24.8K+ 476.92% |
$416K - $792K
|
30K
$353K
|
|
Feb 08, 2024
Q4 2023
|
Bank Of Montreal
Toronto, A6 |
SELL
|
CALL |
-4.5K- 12.86% |
$75.5K - $144K
|
30.5K
$359K
|
|
Feb 14, 2024
Q4 2023
|
Wolverine Trading, LLC
Chicago, IL |
SELL
|
CALL |
-7.5K- 27.78% |
$126K - $240K
|
19.5K
$229K
|
|
Feb 13, 2024
Q4 2023
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
CALL |
-25K- 73.1% |
$420K - $799K
|
9.2K
$108K
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-60.7K- 67.37% |
$1.02M - $1.94M
|
29.4K
$346K
|